Xiaohang Qiao
5PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 08, 2025
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.Sabine E Breukers, Joleen J H Traets, Stan W van Dijk
|Aug 07, 2023
Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment.Anne M van der Leun, Joleen J H Traets, Joris L Vos
|Dec 23, 2021
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.Joris L Vos, Joris B W Elbers, Oscar Krijgsman
|Oct 06, 2020
New insights into the activities and toxicities of the old anticancer drug doxorubicin.Sabina Y van der Zanden, Xiaohang Qiao, Jacques Neefjes
|Jun 20, 2020
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.Xiaohang Qiao, Sabina Y van der Zanden, Dennis P A Wander
Pageof 1
Frequent Collaborators
3 joint publications
John B A G Haanen
3 joint publications
Ton N Schumacher
3 joint publications
Joris L Vos
2 joint publications
Sabina Y van der Zanden
2 joint publications
Charlotte L Zuur
2 joint publications
Michiel W M van den Brekel
2 joint publications
Daniela S Thommen
2 joint publications
Christian U Blank
2 joint publications
Anne M van der Leun
1 joint publications
Bram Westerink
